Progenics Pharmaceuticals competitorsClear all

Progenics Pharmaceuticals's top competitors include Ablynx, Halozyme Therapeutics and Exelixis.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Progenics Pharmaceuticals
Progenics Pharmaceuticals
Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.
Ablynx
Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
Exelixis
Exelixis
Exelixis a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.
Founding Date
Founding Date
1986
Founding Date
2001
Founding Date
1998
Founding Date
1994
Type
Type
Subsidiary
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Billerica, US
Locations
Gent, BE HQ
Gent, BE
Locations
San Diego, US HQ
Locations
Alameda, US HQ
Employees
Employees
10533% increase
Employees
3821% decrease
Employees
1363% increase
Employees
61727% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
5.9 b
Valuation ($)
5.3 b
Twitter followers
Twitter followers
292
Twitter followers
261
Twitter followers
235
Twitter followers
5.7 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
14
Number of tweets (last 30 days)
8
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2
Average likes per tweet (last 30 days)
8.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
92.86%
Percentage of tweets with engagement (last 30 days)
87.5%
Alexa Website Rank
Alexa Website Rank
428737
Alexa Website Rank
389080
Alexa Website Rank
368178
Alexa Website Rank
197956
Employee Rating
Employee Rating
2.8
Employee Rating
3.2
Employee Rating
3.4
Employee Rating
3.8

Financial

Revenue (est.)
Revenue (est.)
$35m (FY, 2019)
Revenue (est.)
€85.2m (FY, 2016)
Revenue (est.)
$267.6m (FY, 2020)
Revenue (est.)
$853.8m (FY, 2018)
Cost of goods
Cost of goods
$3.2m (FY, 2019)
Cost of goods
N/A
Cost of goods
$43.4m (FY, 2020)
Cost of goods
$26.3m (FY, 2018)
Gross profit
Gross profit
$31.8m (FY, 2019)
Gross profit
N/A
Gross profit
$224.2m (FY, 2020)
Gross profit
$827.5m (FY, 2018)
Net income
Net income
($68.6m) (FY, 2019)
Net income
(€1.1m) (FY, 2016)
Net income
$129.1m (FY, 2020)
Net income
$690.1m (FY, 2018)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
50 (Q2, 2017)
Patents (US)
43 (FY, 2020)
Patents (US)
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 498.8m
Total funding raised
$ 45m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Ablynx
HQ
Gent, BE

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.

View company
Halozyme Therapeutics
HQ
San Diego, US
Employees
136↑ 3% increase

Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.

View company
Exelixis
HQ
Alameda, US
Employees
617↑ 27% increase

Exelixis a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.

View company